Carbylan Therapeutics

April 2015 IPO Market Review jdsupra.com
North America , China
San Francisco surgical lighting developer targets $69M IPO bizjournals.com
Silicon Valley , Wall Street , San Francisco Bay Area , San Francisco
Carbylan Therapeutics raises $65M in IPO, stock rises on debut bizjournals.com
San Francisco Bay Area , Wall Street , Palo Alto
Carbylan Therapeutics revives IPO plans, chops target number bizjournals.com
Wall Street , San Francisco Bay Area
Carbylan Therapeutics lines up $4M debt financing after putting off $93M IPO bizjournals.com
Redwood City , Wall Street , Wall Street
Genetic testing firm Invitae tops IPO targets, raises $102M bizjournals.com
Fremont , Redwood City , San Francisco Bay Area , San Francisco
2 more Bay Area life science IPOs coming this week, Invitae sets terms for next week bizjournals.com
Fremont , Redwood City
After big Box debut, next 4 Bay Area IPOs are all in life sciences bizjournals.com
Fremont , San Francisco Bay Area
Medical device maker Avinger ups IPO target by 7%bizjournals.com
San Francisco Bay Area , Redwood City

Frequent names

Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.